Australia Dna Synthesis Market Size & Outlook, 2023-2030
Australia dna synthesis market, 2018-2030 (US$M)
Related Markets
Australia dna synthesis market highlights
- The Australia dna synthesis market generated a revenue of USD 54.2 million in 2023 and is expected to reach USD 127.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 13.1% from 2024 to 2030.
- In terms of segment, oligonucleotide synthesis was the largest revenue generating service type in 2023.
- Gene Synthesis is the most lucrative service type segment registering the fastest growth during the forecast period.
Dna synthesis market data book summary
| Market revenue in 2023 | USD 54.2 million |
| Market revenue in 2030 | USD 127.9 million |
| Growth rate | 13.1% (CAGR from 2023 to 2030) |
| Largest segment | Oligonucleotide synthesis |
| Fastest growing segment | Gene Synthesis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotide Synthesis, Gene Synthesis |
| Key market players worldwide | Thermo Fisher Scientific Inc, Twist Bioscience Corp, Codexis Inc, LGC Group, Eurofins Scientific SE, Genscript Biotech Corp Class H, Bioneer, IBA Lifesciences, Danaher Corp, Quintarabio |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global dna synthesis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China dna synthesis market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 863.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Synthesis Market Scope
DNA Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia dna synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna synthesis market will help companies and investors design strategic landscapes.
Oligonucleotide synthesis was the largest segment with a revenue share of 55.17% in 2023. Horizon Databook has segmented the Australia dna synthesis market based on oligonucleotide synthesis, gene synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
Australia has established and emerging players in the DNA synthesis market, like Genetic Signatures, Starpharma, and Patrys Limited. These companies are actively researching, developing, and commercializing innovative oligonucleotide-based technologies.
Australia has strengths in several areas, such as regenerative medicine and gene editing, where oligonucleotides & gene expression play an important role. In November 2023, the University of Canberra announced expanding and launching Trace DNA Lab, which was anticipated to fuel research activities on environmental DNA applications for better biodiversity & biosecurity.
Furthermore, in September 2022, the Australian Research Council Centre of Excellence in Synthetic Biology entered a partnership with Twist Bioscience to promote and expedite research in synthetic biology. Such partnerships and launches are expected to propel the DNA synthesis market in Australia over the forecast period.
Reasons to subscribe to Australia dna synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia dna synthesis market databook
-
Our clientele includes a mix of dna synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia dna synthesis market, including forecasts for subscribers. This country databook contains high-level insights into Australia dna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia dna synthesis market report size, by service type, 2018-2030 (US$M)
Australia DNA Synthesis Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
